OCA

Octagon Capital Advisors Portfolio holdings

AUM $456M
This Quarter Return
+23.92%
1 Year Return
+48.55%
3 Year Return
+560.4%
5 Year Return
10 Year Return
AUM
$579M
AUM Growth
+$579M
Cap. Flow
+$124M
Cap. Flow %
21.39%
Top 10 Hldgs %
77.06%
Holding
40
New
20
Increased
2
Reduced
6
Closed
5
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
APLS icon
1
Apellis Pharmaceuticals
APLS
$3.48B
$171M 29.5% 2,503,059 -80,000 -3% -$5.46M
RCUS icon
2
Arcus Biosciences
RCUS
$1.13B
$69.8M 12.05% 2,668,316 -1,658 -0.1% -$43.4K
KDNY
3
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$50.2M 8.66% 2,551,703
HZNP
4
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$38.7M 6.67% 624,500 +294,500 +89% +$18.2M
GOSS icon
5
Gossamer Bio
GOSS
$562M
$24.5M 4.23% 2,045,442 -712,627 -26% -$8.54M
TNDM icon
6
Tandem Diabetes Care
TNDM
$845M
$22.7M 3.92% +474,929 New +$22.7M
CLDX icon
7
Celldex Therapeutics
CLDX
$1.47B
$21.4M 3.69% 761,398
XBI icon
8
SPDR S&P Biotech ETF
XBI
$5.07B
$19.3M 3.33% 243,400
MRTX
9
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$15.4M 2.66% +221,000 New +$15.4M
VRNA
10
Verona Pharma
VRNA
$9.16B
$13.5M 2.34% +1,324,868 New +$13.5M
VERA icon
11
Vera Therapeutics
VERA
$1.38B
$11.4M 1.96% 533,264 -41,736 -7% -$889K
HRMY icon
12
Harmony Biosciences
HRMY
$2.12B
$10.8M 1.86% +243,500 New +$10.8M
ITCI
13
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$10.3M 1.77% +220,953 New +$10.3M
STOK icon
14
Stoke Therapeutics
STOK
$1.08B
$9.8M 1.69% 763,456
BBIO icon
15
BridgeBio Pharma
BBIO
$9.89B
$9.28M 1.6% 933,743
ALPN
16
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$8.82M 1.52% +1,225,000 New +$8.82M
ASND icon
17
Ascendis Pharma
ASND
$11.8B
$8.62M 1.49% +83,500 New +$8.62M
KRTX
18
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$7.76M 1.34% +34,500 New +$7.76M
ALNY icon
19
Alnylam Pharmaceuticals
ALNY
$58.5B
$7.47M 1.29% +37,300 New +$7.47M
FATE icon
20
Fate Therapeutics
FATE
$120M
$7.42M 1.28% +331,096 New +$7.42M
XLO icon
21
Xilio Therapeutics
XLO
$36.3M
$7.06M 1.22% +2,425,000 New +$7.06M
RNA icon
22
Avidity Biosciences
RNA
$5.99B
$6.2M 1.07% 379,629 +57,988 +18% +$947K
FDMT icon
23
4D Molecular Therapeutics
FDMT
$288M
$4.02M 0.69% 499,996 -132,749 -21% -$1.07M
NUVL icon
24
Nuvalent
NUVL
$5.52B
$3.89M 0.67% +200,000 New +$3.89M
JNCE
25
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$3.28M 0.57% +1,400,000 New +$3.28M